Brain image with scientist, stairs and torch highlighting alzheimer’s research is increasingly focused on links to sleep and other behaviors

Alzheimer’s research focuses on links to sleep and other behaviours

Alzheimer’s research is increasingly focused on links to sleep and other behaviors according to a new report released by Elsevier. To coincide with World Alzheimer’s...
Novartis Luxturna®recommended by NICE for use on the NHS.

Novartis Luxturna®▼ recommended on NHS for rare inherited eye disorder

Novartis Luxturna®, a novel gene therapy treatment for rare inherited eye disorder, has been recommended by NICE for use on the NHS. The draft highly-specialised...
Sandoz announces global deal with Polpharma

Sandoz announce global deal to comercialise natalizumab

Sandoz, a Novartis division and a global leader in biosimilars, has entered into a global commercialisation agreement with Polpharma Biologics for a proposed natalizumab...
Results for Brilinta in Phae III THEMIS trial published

AstraZeneca’s Brilinta reduces CV events risk in Phase III trial

AstraZeneca has announced detailed results from the positive Phase III THEMIS trial which showed Brilinta (ticagrelor) plus aspirin reduced the relative risk for the...
Northern Antibiotics is working on a new antibiotic molecule that they hope will become a weapon against antibiotic bacteria.

New antibiotic molecule being developed in fight against antibiotic-resistant bacteria

Northern Antibiotics is working on a new antibiotic molecule that it hopes will become a weapon against antibiotic bacteria. Each year, around 60,000 deaths are...
New research could boost innovative cancer treatments

New research could boost innovative cancer treatments

Removing cancer's protective barrier could boost effectiveness of innovative cancer treatments like immunotherapy, according to early research part-funded by Cancer Research UK. In the study,...
MSD and the Francis Crick Institute have started a unique new motor neurone disease collaboration to understand the causes and identify future treatments.

MSD and Francis Crick Institute launch new motor neurone disease collaboration

Scientists at MSD and the Francis Crick Institute have started a unique new motor neurone disease collaboration to understand the causes and identify potential...
NICE to work with GW Pharma on cannabidiol evaluation

NICE to work with GW Pharma on cannabidiol evaluation

NICE has announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of...
NHS Spine marks five years of being run as an open source service

NHS Spine marks five-year anniversary

NHS Spine is marking five years since it was brought in house by NHS Digital and run as an open source service for the...
Positive results for long acting injectable HIV treatment regimen

Positive phase III study results for injectable HIV-treatment regimen

ViiV Healthcare has announced positive headline results from its global phase III ATLAS-2M study of the investigational, long-acting, injectable, 2-drug regimen (2DR) of ViiV...

Latest articles

Image of a man pumping air into a pund symbol to indicate drug firms admitting to colluding to keep up prices of antidepressants

Drug firms admit to colluding to keep up prices of antidepressants

Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...
Licensing status of Avastin updated by MHRA

Licensing status of Avastin updated by MHRA

The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners

PM Society Digital Award Winners 2019

Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
Licensing status of Avastin updated by MHRA

Licensing status of Avastin updated by MHRA

The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners

PM Society Digital Award Winners 2019

Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
image of a hospital and ambulance showing poor diabetes control costs the NHS £3bn in avoidable treatment

Poor diabetes control costs the NHS £3bn in avoidable treatment

New research finds that poor diabetes control costs the NHS £3bn in potentially avoidable hospital treatment in England. The findings, being presented at this year’s...
Image of a man pumping air into a pund symbol to indicate drug firms admitting to colluding to keep up prices of antidepressants

Drug firms admit to colluding to keep up prices of antidepressants

Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription